Helong Zhao

University of Shanghai for Science and Technology

Also affiliated with German Cancer Research Center, Heidelberg University, Jiading District Central Hospital, Fred Hutch Cancer Center, Versiti Blood Center of Wisconsin, Shanghai University of Medicine and Health Sciences

Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Imatinib is not a potent anti-SARS-CoV-2 drug”.

Imatinib is not a potent anti-SARS-CoV-2 drug

Leukemia(2020)10.1038/s41375-020-01045-9

N/A

2.6DataRank · unranked

45 citations

Michelle Mendenhall, Michael W. Deininger, Helong Zhao

Eradicating residual chronic myeloid leukaemia: basic research lost in translation

The Lancet Haematology(2021)10.1016/s2352-3026(21)00001-6

N/A

0.435DataRank · unranked

8 citations

Michael W. Deininger, Helong Zhao

Lipopolysaccharide from the commensal microbiota of the breast enhances cancer growth: role of S100A7 and TLR4

Molecular Oncology(2021)10.1002/1878-0261.12975

N/A

0DataRank · unranked

39 citations

Ajeet Kumar Verma, Helong Zhao, Manish Charan, Dinesh K. Ahirwar, Sashi Kant +4 more

Neuroinflammatory disease disrupts the blood-CNS barrier via crosstalk between proinflammatory and endothelial-to-mesenchymal-transition signaling

Neuron(2022)10.1016/j.neuron.2022.07.015

N/A

0DataRank · unranked

39 citations

Helong Zhao, Daniel Fang, Chadwick T. Davis, Dallas Shi, KaChon Lei +19 more